Tadalafil dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Tadalafil}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click <u>here'''''</u> ==Dosage Forms and Strengths...")
 
Line 7: Line 7:
==Dosage Forms and Strengths==
==Dosage Forms and Strengths==


 
20 mg, orange, film-coated, almond-shaped tablets (not scored) debossed with “4467”.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ADCIRCA (TADALAFIL) TABLET [UNITED THERAPEUTICS CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff61b237-be8e-461b-8114-78c52a8ad0ae | publisher =  | date =  | accessdate = 7 February 2014 }}</ref>
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ADCIRCA (TADALAFIL) TABLET [UNITED THERAPEUTICS CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff61b237-be8e-461b-8114-78c52a8ad0ae | publisher =  | date =  | accessdate = 7 February 2014 }}</ref>


==References==
==References==

Revision as of 22:40, 7 February 2014

Tadalafil
ADCIRCA (tadalafil) tablet ® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here

Dosage Forms and Strengths

20 mg, orange, film-coated, almond-shaped tablets (not scored) debossed with “4467”.[1]

References

  1. "ADCIRCA (TADALAFIL) TABLET [UNITED THERAPEUTICS CORPORATION]". Retrieved 7 February 2014.